nodes	percent_of_prediction	percent_of_DWPC	metapath
Pindolol—CYP2D6—Niacin—atherosclerosis	0.125	0.3	CbGbCtD
Pindolol—CYP2D6—Simvastatin—atherosclerosis	0.0991	0.237	CbGbCtD
Pindolol—CYP2D6—Pravastatin—atherosclerosis	0.097	0.232	CbGbCtD
Pindolol—CYP2D6—Lovastatin—atherosclerosis	0.097	0.232	CbGbCtD
Pindolol—Musculoskeletal disorder—Rosuvastatin—atherosclerosis	0.0142	0.0331	CcSEcCtD
Pindolol—Musculoskeletal disorder—Simvastatin—atherosclerosis	0.0113	0.0262	CcSEcCtD
Pindolol—Ache—Lovastatin—atherosclerosis	0.00933	0.0217	CcSEcCtD
Pindolol—Ache—Simvastatin—atherosclerosis	0.00873	0.0203	CcSEcCtD
Pindolol—Ache—Pravastatin—atherosclerosis	0.00789	0.0184	CcSEcCtD
Pindolol—Sleep disturbance—Simvastatin—atherosclerosis	0.00719	0.0167	CcSEcCtD
Pindolol—Transaminases increased—Lovastatin—atherosclerosis	0.00708	0.0165	CcSEcCtD
Pindolol—Transaminases increased—Ezetimibe—atherosclerosis	0.00695	0.0162	CcSEcCtD
Pindolol—Transaminases increased—Simvastatin—atherosclerosis	0.00662	0.0154	CcSEcCtD
Pindolol—Sleep disturbance—Pravastatin—atherosclerosis	0.0065	0.0151	CcSEcCtD
Pindolol—Transaminases increased—Pravastatin—atherosclerosis	0.00599	0.0139	CcSEcCtD
Pindolol—Heartburn—Niacin—atherosclerosis	0.00538	0.0125	CcSEcCtD
Pindolol—Heartburn—Pravastatin—atherosclerosis	0.00529	0.0123	CcSEcCtD
Pindolol—Nightmare—Rosuvastatin—atherosclerosis	0.00491	0.0114	CcSEcCtD
Pindolol—Sleep disorder—Rosuvastatin—atherosclerosis	0.00426	0.00991	CcSEcCtD
Pindolol—Nightmare—Simvastatin—atherosclerosis	0.00389	0.00905	CcSEcCtD
Pindolol—Nightmare—Pravastatin—atherosclerosis	0.00352	0.00818	CcSEcCtD
Pindolol—Sleep disorder—Simvastatin—atherosclerosis	0.00338	0.00786	CcSEcCtD
Pindolol—Hot flush—Ezetimibe—atherosclerosis	0.00328	0.00763	CcSEcCtD
Pindolol—Menopausal symptoms—Ezetimibe—atherosclerosis	0.00325	0.00756	CcSEcCtD
Pindolol—Sleep disorder—Pravastatin—atherosclerosis	0.00305	0.00711	CcSEcCtD
Pindolol—Depression—Rosuvastatin—atherosclerosis	0.00284	0.00659	CcSEcCtD
Pindolol—Hot flush—Pravastatin—atherosclerosis	0.00283	0.00657	CcSEcCtD
Pindolol—Cramp muscle—Lovastatin—atherosclerosis	0.00282	0.00655	CcSEcCtD
Pindolol—Menopausal symptoms—Pravastatin—atherosclerosis	0.0028	0.00652	CcSEcCtD
Pindolol—Cramp muscle—Ezetimibe—atherosclerosis	0.00276	0.00642	CcSEcCtD
Pindolol—Cramp muscle—Simvastatin—atherosclerosis	0.00263	0.00613	CcSEcCtD
Pindolol—Abdominal discomfort—Lovastatin—atherosclerosis	0.00259	0.00603	CcSEcCtD
Pindolol—Erectile dysfunction—Lovastatin—atherosclerosis	0.00249	0.00579	CcSEcCtD
Pindolol—Orthostatic hypotension—Niacin—atherosclerosis	0.00245	0.00571	CcSEcCtD
Pindolol—Erectile dysfunction—Ezetimibe—atherosclerosis	0.00244	0.00568	CcSEcCtD
Pindolol—Abdominal discomfort—Simvastatin—atherosclerosis	0.00242	0.00564	CcSEcCtD
Pindolol—Cramp muscle—Pravastatin—atherosclerosis	0.00238	0.00554	CcSEcCtD
Pindolol—Erectile dysfunction—Simvastatin—atherosclerosis	0.00233	0.00542	CcSEcCtD
Pindolol—Depression—Simvastatin—atherosclerosis	0.00225	0.00523	CcSEcCtD
Pindolol—Mental disorder—Rosuvastatin—atherosclerosis	0.00224	0.0052	CcSEcCtD
Pindolol—Flatulence—Rosuvastatin—atherosclerosis	0.00219	0.00509	CcSEcCtD
Pindolol—Erectile dysfunction—Niacin—atherosclerosis	0.00214	0.00497	CcSEcCtD
Pindolol—Erectile dysfunction—Pravastatin—atherosclerosis	0.00211	0.0049	CcSEcCtD
Pindolol—Weight increased—Pravastatin—atherosclerosis	0.00208	0.00484	CcSEcCtD
Pindolol—Depression—Pravastatin—atherosclerosis	0.00203	0.00473	CcSEcCtD
Pindolol—Sweating—Niacin—atherosclerosis	0.00198	0.00462	CcSEcCtD
Pindolol—Angiopathy—Ezetimibe—atherosclerosis	0.00193	0.00448	CcSEcCtD
Pindolol—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00191	0.00445	CcSEcCtD
Pindolol—Arthralgia—Rosuvastatin—atherosclerosis	0.00189	0.0044	CcSEcCtD
Pindolol—Myalgia—Rosuvastatin—atherosclerosis	0.00189	0.0044	CcSEcCtD
Pindolol—Mental disorder—Ezetimibe—atherosclerosis	0.00186	0.00432	CcSEcCtD
Pindolol—Flatulence—Lovastatin—atherosclerosis	0.00186	0.00432	CcSEcCtD
Pindolol—Confusional state—Rosuvastatin—atherosclerosis	0.00183	0.00425	CcSEcCtD
Pindolol—Flatulence—Ezetimibe—atherosclerosis	0.00182	0.00423	CcSEcCtD
Pindolol—Muscle spasms—Lovastatin—atherosclerosis	0.00181	0.00421	CcSEcCtD
Pindolol—Visual impairment—Niacin—atherosclerosis	0.00179	0.00416	CcSEcCtD
Pindolol—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00178	0.00414	CcSEcCtD
Pindolol—Muscle spasms—Ezetimibe—atherosclerosis	0.00178	0.00413	CcSEcCtD
Pindolol—Mental disorder—Simvastatin—atherosclerosis	0.00177	0.00412	CcSEcCtD
Pindolol—Tremor—Lovastatin—atherosclerosis	0.00176	0.0041	CcSEcCtD
Pindolol—Visual impairment—Pravastatin—atherosclerosis	0.00176	0.0041	CcSEcCtD
Pindolol—Flatulence—Simvastatin—atherosclerosis	0.00174	0.00404	CcSEcCtD
Pindolol—Tinnitus—Niacin—atherosclerosis	0.00173	0.00403	CcSEcCtD
Pindolol—Tinnitus—Pravastatin—atherosclerosis	0.00171	0.00397	CcSEcCtD
Pindolol—Cardiac disorder—Pravastatin—atherosclerosis	0.0017	0.00395	CcSEcCtD
Pindolol—Muscle spasms—Simvastatin—atherosclerosis	0.00169	0.00394	CcSEcCtD
Pindolol—Vertigo—Lovastatin—atherosclerosis	0.00169	0.00394	CcSEcCtD
Pindolol—Angiopathy—Niacin—atherosclerosis	0.00169	0.00392	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00165	0.00384	CcSEcCtD
Pindolol—Tremor—Simvastatin—atherosclerosis	0.00165	0.00384	CcSEcCtD
Pindolol—Insomnia—Rosuvastatin—atherosclerosis	0.00164	0.00382	CcSEcCtD
Pindolol—Palpitations—Ezetimibe—atherosclerosis	0.00163	0.0038	CcSEcCtD
Pindolol—Paraesthesia—Rosuvastatin—atherosclerosis	0.00163	0.00379	CcSEcCtD
Pindolol—Arthralgia—Lovastatin—atherosclerosis	0.0016	0.00373	CcSEcCtD
Pindolol—Myalgia—Lovastatin—atherosclerosis	0.0016	0.00373	CcSEcCtD
Pindolol—Chest pain—Lovastatin—atherosclerosis	0.0016	0.00373	CcSEcCtD
Pindolol—Anxiety—Lovastatin—atherosclerosis	0.0016	0.00372	CcSEcCtD
Pindolol—Dyspepsia—Rosuvastatin—atherosclerosis	0.0016	0.00371	CcSEcCtD
Pindolol—Flatulence—Niacin—atherosclerosis	0.00159	0.00371	CcSEcCtD
Pindolol—Tension—Niacin—atherosclerosis	0.00159	0.00369	CcSEcCtD
Pindolol—Vertigo—Simvastatin—atherosclerosis	0.00158	0.00368	CcSEcCtD
Pindolol—Arthralgia—Ezetimibe—atherosclerosis	0.00157	0.00366	CcSEcCtD
Pindolol—Chest pain—Ezetimibe—atherosclerosis	0.00157	0.00366	CcSEcCtD
Pindolol—Myalgia—Ezetimibe—atherosclerosis	0.00157	0.00366	CcSEcCtD
Pindolol—Nervousness—Niacin—atherosclerosis	0.00157	0.00365	CcSEcCtD
Pindolol—Flatulence—Pravastatin—atherosclerosis	0.00157	0.00365	CcSEcCtD
Pindolol—Dry mouth—Lovastatin—atherosclerosis	0.00157	0.00365	CcSEcCtD
Pindolol—Tension—Pravastatin—atherosclerosis	0.00156	0.00363	CcSEcCtD
Pindolol—Muscle spasms—Niacin—atherosclerosis	0.00156	0.00362	CcSEcCtD
Pindolol—Pain—Rosuvastatin—atherosclerosis	0.00155	0.00361	CcSEcCtD
Pindolol—Constipation—Rosuvastatin—atherosclerosis	0.00155	0.00361	CcSEcCtD
Pindolol—Confusional state—Lovastatin—atherosclerosis	0.00155	0.0036	CcSEcCtD
Pindolol—Nervousness—Pravastatin—atherosclerosis	0.00155	0.0036	CcSEcCtD
Pindolol—Dry mouth—Ezetimibe—atherosclerosis	0.00154	0.00358	CcSEcCtD
Pindolol—Muscle spasms—Pravastatin—atherosclerosis	0.00153	0.00356	CcSEcCtD
Pindolol—Confusional state—Ezetimibe—atherosclerosis	0.00152	0.00354	CcSEcCtD
Pindolol—Arthralgia—Simvastatin—atherosclerosis	0.0015	0.00349	CcSEcCtD
Pindolol—Chest pain—Simvastatin—atherosclerosis	0.0015	0.00349	CcSEcCtD
Pindolol—Myalgia—Simvastatin—atherosclerosis	0.0015	0.00349	CcSEcCtD
Pindolol—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00149	0.00348	CcSEcCtD
Pindolol—Anxiety—Simvastatin—atherosclerosis	0.00149	0.00348	CcSEcCtD
Pindolol—Tremor—Pravastatin—atherosclerosis	0.00149	0.00347	CcSEcCtD
Pindolol—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00148	0.00345	CcSEcCtD
Pindolol—Nervous system disorder—Ezetimibe—atherosclerosis	0.00148	0.00344	CcSEcCtD
Pindolol—Vertigo—Niacin—atherosclerosis	0.00145	0.00338	CcSEcCtD
Pindolol—Syncope—Niacin—atherosclerosis	0.00145	0.00337	CcSEcCtD
Pindolol—Confusional state—Simvastatin—atherosclerosis	0.00145	0.00337	CcSEcCtD
Pindolol—Oedema—Simvastatin—atherosclerosis	0.00144	0.00334	CcSEcCtD
Pindolol—Abdominal pain—Rosuvastatin—atherosclerosis	0.00143	0.00333	CcSEcCtD
Pindolol—Vertigo—Pravastatin—atherosclerosis	0.00143	0.00333	CcSEcCtD
Pindolol—Palpitations—Niacin—atherosclerosis	0.00143	0.00332	CcSEcCtD
Pindolol—Loss of consciousness—Niacin—atherosclerosis	0.00142	0.00331	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.0014	0.00326	CcSEcCtD
Pindolol—Insomnia—Lovastatin—atherosclerosis	0.00139	0.00323	CcSEcCtD
Pindolol—Paraesthesia—Lovastatin—atherosclerosis	0.00138	0.00321	CcSEcCtD
Pindolol—Arthralgia—Niacin—atherosclerosis	0.00138	0.0032	CcSEcCtD
Pindolol—Myalgia—Niacin—atherosclerosis	0.00138	0.0032	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00137	0.00319	CcSEcCtD
Pindolol—Dyspnoea—Lovastatin—atherosclerosis	0.00137	0.00319	CcSEcCtD
Pindolol—Insomnia—Ezetimibe—atherosclerosis	0.00136	0.00317	CcSEcCtD
Pindolol—Chest pain—Pravastatin—atherosclerosis	0.00136	0.00315	CcSEcCtD
Pindolol—Myalgia—Pravastatin—atherosclerosis	0.00136	0.00315	CcSEcCtD
Pindolol—Arthralgia—Pravastatin—atherosclerosis	0.00136	0.00315	CcSEcCtD
Pindolol—Paraesthesia—Ezetimibe—atherosclerosis	0.00135	0.00315	CcSEcCtD
Pindolol—Dyspepsia—Lovastatin—atherosclerosis	0.00135	0.00315	CcSEcCtD
Pindolol—Anxiety—Pravastatin—atherosclerosis	0.00135	0.00314	CcSEcCtD
Pindolol—Dry mouth—Niacin—atherosclerosis	0.00135	0.00313	CcSEcCtD
Pindolol—Dyspnoea—Ezetimibe—atherosclerosis	0.00134	0.00313	CcSEcCtD
Pindolol—Dyspepsia—Ezetimibe—atherosclerosis	0.00133	0.00309	CcSEcCtD
Pindolol—Fatigue—Lovastatin—atherosclerosis	0.00133	0.00308	CcSEcCtD
Pindolol—Oedema—Niacin—atherosclerosis	0.00132	0.00307	CcSEcCtD
Pindolol—Pain—Lovastatin—atherosclerosis	0.00131	0.00306	CcSEcCtD
Pindolol—Constipation—Lovastatin—atherosclerosis	0.00131	0.00306	CcSEcCtD
Pindolol—Confusional state—Pravastatin—atherosclerosis	0.00131	0.00305	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00131	0.00305	CcSEcCtD
Pindolol—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.0013	0.00303	CcSEcCtD
Pindolol—Asthenia—Rosuvastatin—atherosclerosis	0.0013	0.00303	CcSEcCtD
Pindolol—Insomnia—Simvastatin—atherosclerosis	0.0013	0.00302	CcSEcCtD
Pindolol—Oedema—Pravastatin—atherosclerosis	0.0013	0.00302	CcSEcCtD
Pindolol—Fatigue—Ezetimibe—atherosclerosis	0.0013	0.00302	CcSEcCtD
Pindolol—Shock—Niacin—atherosclerosis	0.0013	0.00302	CcSEcCtD
Pindolol—Paraesthesia—Simvastatin—atherosclerosis	0.00129	0.003	CcSEcCtD
Pindolol—Pain—Ezetimibe—atherosclerosis	0.00129	0.003	CcSEcCtD
Pindolol—Constipation—Ezetimibe—atherosclerosis	0.00129	0.003	CcSEcCtD
Pindolol—Tachycardia—Niacin—atherosclerosis	0.00129	0.003	CcSEcCtD
Pindolol—Pruritus—Rosuvastatin—atherosclerosis	0.00128	0.00298	CcSEcCtD
Pindolol—Dyspnoea—Simvastatin—atherosclerosis	0.00128	0.00298	CcSEcCtD
Pindolol—Hyperhidrosis—Niacin—atherosclerosis	0.00128	0.00297	CcSEcCtD
Pindolol—Feeling abnormal—Lovastatin—atherosclerosis	0.00127	0.00295	CcSEcCtD
Pindolol—Dyspepsia—Simvastatin—atherosclerosis	0.00127	0.00294	CcSEcCtD
Pindolol—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00126	0.00292	CcSEcCtD
Pindolol—Hyperhidrosis—Pravastatin—atherosclerosis	0.00126	0.00292	CcSEcCtD
Pindolol—Feeling abnormal—Ezetimibe—atherosclerosis	0.00124	0.00289	CcSEcCtD
Pindolol—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00124	0.00289	CcSEcCtD
Pindolol—Diarrhoea—Rosuvastatin—atherosclerosis	0.00124	0.00289	CcSEcCtD
Pindolol—Fatigue—Simvastatin—atherosclerosis	0.00124	0.00288	CcSEcCtD
Pindolol—Hypotension—Niacin—atherosclerosis	0.00123	0.00287	CcSEcCtD
Pindolol—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00123	0.00287	CcSEcCtD
Pindolol—Pain—Simvastatin—atherosclerosis	0.00123	0.00286	CcSEcCtD
Pindolol—Constipation—Simvastatin—atherosclerosis	0.00123	0.00286	CcSEcCtD
Pindolol—Abdominal pain—Lovastatin—atherosclerosis	0.00121	0.00283	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Niacin—atherosclerosis	0.0012	0.0028	CcSEcCtD
Pindolol—Dizziness—Rosuvastatin—atherosclerosis	0.0012	0.00279	CcSEcCtD
Pindolol—Insomnia—Niacin—atherosclerosis	0.00119	0.00278	CcSEcCtD
Pindolol—Abdominal pain—Ezetimibe—atherosclerosis	0.00119	0.00277	CcSEcCtD
Pindolol—Paraesthesia—Niacin—atherosclerosis	0.00119	0.00276	CcSEcCtD
Pindolol—Feeling abnormal—Simvastatin—atherosclerosis	0.00118	0.00276	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00118	0.00275	CcSEcCtD
Pindolol—Dyspnoea—Niacin—atherosclerosis	0.00118	0.00274	CcSEcCtD
Pindolol—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00118	0.00273	CcSEcCtD
Pindolol—Insomnia—Pravastatin—atherosclerosis	0.00118	0.00273	CcSEcCtD
Pindolol—Somnolence—Niacin—atherosclerosis	0.00117	0.00273	CcSEcCtD
Pindolol—Paraesthesia—Pravastatin—atherosclerosis	0.00117	0.00271	CcSEcCtD
Pindolol—Dyspepsia—Niacin—atherosclerosis	0.00116	0.0027	CcSEcCtD
Pindolol—Dyspnoea—Pravastatin—atherosclerosis	0.00116	0.0027	CcSEcCtD
Pindolol—Dyspepsia—Pravastatin—atherosclerosis	0.00114	0.00266	CcSEcCtD
Pindolol—Rash—Rosuvastatin—atherosclerosis	0.00114	0.00266	CcSEcCtD
Pindolol—Dermatitis—Rosuvastatin—atherosclerosis	0.00114	0.00266	CcSEcCtD
Pindolol—Gastrointestinal disorder—Niacin—atherosclerosis	0.00114	0.00265	CcSEcCtD
Pindolol—Abdominal pain—Simvastatin—atherosclerosis	0.00114	0.00264	CcSEcCtD
Pindolol—Headache—Rosuvastatin—atherosclerosis	0.00114	0.00264	CcSEcCtD
Pindolol—Pain—Niacin—atherosclerosis	0.00113	0.00263	CcSEcCtD
Pindolol—Fatigue—Pravastatin—atherosclerosis	0.00112	0.00261	CcSEcCtD
Pindolol—Pain—Pravastatin—atherosclerosis	0.00111	0.00259	CcSEcCtD
Pindolol—Constipation—Pravastatin—atherosclerosis	0.00111	0.00259	CcSEcCtD
Pindolol—Asthenia—Lovastatin—atherosclerosis	0.0011	0.00256	CcSEcCtD
Pindolol—Pruritus—Lovastatin—atherosclerosis	0.00109	0.00253	CcSEcCtD
Pindolol—Asthenia—Ezetimibe—atherosclerosis	0.00108	0.00252	CcSEcCtD
Pindolol—Gastrointestinal pain—Niacin—atherosclerosis	0.00108	0.00251	CcSEcCtD
Pindolol—Nausea—Rosuvastatin—atherosclerosis	0.00108	0.00251	CcSEcCtD
Pindolol—Feeling abnormal—Pravastatin—atherosclerosis	0.00107	0.00249	CcSEcCtD
Pindolol—Pruritus—Ezetimibe—atherosclerosis	0.00107	0.00248	CcSEcCtD
Pindolol—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00106	0.00247	CcSEcCtD
Pindolol—Diarrhoea—Lovastatin—atherosclerosis	0.00105	0.00245	CcSEcCtD
Pindolol—Abdominal pain—Niacin—atherosclerosis	0.00104	0.00243	CcSEcCtD
Pindolol—Asthenia—Simvastatin—atherosclerosis	0.00103	0.0024	CcSEcCtD
Pindolol—Diarrhoea—Ezetimibe—atherosclerosis	0.00103	0.0024	CcSEcCtD
Pindolol—Abdominal pain—Pravastatin—atherosclerosis	0.00103	0.00239	CcSEcCtD
Pindolol—Pruritus—Simvastatin—atherosclerosis	0.00102	0.00237	CcSEcCtD
Pindolol—Dizziness—Lovastatin—atherosclerosis	0.00102	0.00236	CcSEcCtD
Pindolol—Dizziness—Ezetimibe—atherosclerosis	0.000997	0.00232	CcSEcCtD
Pindolol—Diarrhoea—Simvastatin—atherosclerosis	0.000984	0.00229	CcSEcCtD
Pindolol—Vomiting—Lovastatin—atherosclerosis	0.000977	0.00227	CcSEcCtD
Pindolol—Rash—Lovastatin—atherosclerosis	0.000969	0.00225	CcSEcCtD
Pindolol—Dermatitis—Lovastatin—atherosclerosis	0.000968	0.00225	CcSEcCtD
Pindolol—Headache—Lovastatin—atherosclerosis	0.000963	0.00224	CcSEcCtD
Pindolol—Vomiting—Ezetimibe—atherosclerosis	0.000958	0.00223	CcSEcCtD
Pindolol—Dizziness—Simvastatin—atherosclerosis	0.000951	0.00221	CcSEcCtD
Pindolol—Rash—Ezetimibe—atherosclerosis	0.00095	0.00221	CcSEcCtD
Pindolol—Dermatitis—Ezetimibe—atherosclerosis	0.00095	0.00221	CcSEcCtD
Pindolol—Asthenia—Niacin—atherosclerosis	0.000947	0.0022	CcSEcCtD
Pindolol—Headache—Ezetimibe—atherosclerosis	0.000944	0.0022	CcSEcCtD
Pindolol—Pruritus—Niacin—atherosclerosis	0.000934	0.00217	CcSEcCtD
Pindolol—Asthenia—Pravastatin—atherosclerosis	0.000933	0.00217	CcSEcCtD
Pindolol—Pruritus—Pravastatin—atherosclerosis	0.00092	0.00214	CcSEcCtD
Pindolol—Vomiting—Simvastatin—atherosclerosis	0.000914	0.00213	CcSEcCtD
Pindolol—Nausea—Lovastatin—atherosclerosis	0.000913	0.00212	CcSEcCtD
Pindolol—Rash—Simvastatin—atherosclerosis	0.000906	0.00211	CcSEcCtD
Pindolol—Dermatitis—Simvastatin—atherosclerosis	0.000906	0.00211	CcSEcCtD
Pindolol—Diarrhoea—Niacin—atherosclerosis	0.000903	0.0021	CcSEcCtD
Pindolol—Headache—Simvastatin—atherosclerosis	0.000901	0.00209	CcSEcCtD
Pindolol—Nausea—Ezetimibe—atherosclerosis	0.000895	0.00208	CcSEcCtD
Pindolol—Diarrhoea—Pravastatin—atherosclerosis	0.000889	0.00207	CcSEcCtD
Pindolol—Dizziness—Niacin—atherosclerosis	0.000873	0.00203	CcSEcCtD
Pindolol—Dizziness—Pravastatin—atherosclerosis	0.000859	0.002	CcSEcCtD
Pindolol—Nausea—Simvastatin—atherosclerosis	0.000854	0.00199	CcSEcCtD
Pindolol—Vomiting—Niacin—atherosclerosis	0.000839	0.00195	CcSEcCtD
Pindolol—Rash—Niacin—atherosclerosis	0.000832	0.00194	CcSEcCtD
Pindolol—Dermatitis—Niacin—atherosclerosis	0.000832	0.00193	CcSEcCtD
Pindolol—Headache—Niacin—atherosclerosis	0.000827	0.00192	CcSEcCtD
Pindolol—Vomiting—Pravastatin—atherosclerosis	0.000826	0.00192	CcSEcCtD
Pindolol—Rash—Pravastatin—atherosclerosis	0.000819	0.00191	CcSEcCtD
Pindolol—Dermatitis—Pravastatin—atherosclerosis	0.000819	0.0019	CcSEcCtD
Pindolol—Headache—Pravastatin—atherosclerosis	0.000814	0.00189	CcSEcCtD
Pindolol—Nausea—Niacin—atherosclerosis	0.000784	0.00182	CcSEcCtD
Pindolol—Nausea—Pravastatin—atherosclerosis	0.000772	0.0018	CcSEcCtD
Pindolol—ADRB3—Signaling Pathways—APOA1—atherosclerosis	5.12e-05	0.000338	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—GHRL—atherosclerosis	5.11e-05	0.000337	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PLAT—atherosclerosis	5.11e-05	0.000337	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PARP1—atherosclerosis	5.11e-05	0.000337	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CYBA—atherosclerosis	5.11e-05	0.000337	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—AGT—atherosclerosis	5.08e-05	0.000335	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—PIK3CG—atherosclerosis	5.06e-05	0.000334	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—EDNRA—atherosclerosis	5.02e-05	0.000331	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CCR2—atherosclerosis	5.02e-05	0.000331	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PARP1—atherosclerosis	5e-05	0.00033	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PLAT—atherosclerosis	5e-05	0.00033	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—GHRL—atherosclerosis	5e-05	0.00033	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CYBA—atherosclerosis	4.99e-05	0.00033	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MMP3—atherosclerosis	4.99e-05	0.000329	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—IGF2—atherosclerosis	4.97e-05	0.000328	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—PIK3CG—atherosclerosis	4.95e-05	0.000327	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—ESR1—atherosclerosis	4.94e-05	0.000326	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—F2—atherosclerosis	4.91e-05	0.000324	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYP27A1—atherosclerosis	4.9e-05	0.000324	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PLAT—atherosclerosis	4.89e-05	0.000323	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—GHRL—atherosclerosis	4.89e-05	0.000323	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PARP1—atherosclerosis	4.89e-05	0.000323	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—F2—atherosclerosis	4.88e-05	0.000322	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—APOB—atherosclerosis	4.82e-05	0.000318	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—F2—atherosclerosis	4.8e-05	0.000317	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—CXCL8—atherosclerosis	4.78e-05	0.000316	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—EDN1—atherosclerosis	4.75e-05	0.000313	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CCL5—atherosclerosis	4.71e-05	0.000311	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—PIK3CG—atherosclerosis	4.7e-05	0.00031	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—F2—atherosclerosis	4.69e-05	0.00031	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—PIK3CG—atherosclerosis	4.67e-05	0.000309	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	4.65e-05	0.000307	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—APOA2—atherosclerosis	4.65e-05	0.000307	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	4.65e-05	0.000307	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ALOX15—atherosclerosis	4.65e-05	0.000307	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—LPL—atherosclerosis	4.6e-05	0.000304	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—PIK3CG—atherosclerosis	4.59e-05	0.000303	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ABCG5—atherosclerosis	4.59e-05	0.000303	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—PIK3CG—atherosclerosis	4.49e-05	0.000297	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—KNG1—atherosclerosis	4.49e-05	0.000296	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PRKCG—atherosclerosis	4.48e-05	0.000296	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—MAPK3—atherosclerosis	4.48e-05	0.000296	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—AGTR1—atherosclerosis	4.46e-05	0.000294	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—LPA—atherosclerosis	4.43e-05	0.000293	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—INS—atherosclerosis	4.42e-05	0.000292	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—KNG1—atherosclerosis	4.39e-05	0.00029	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—CCL2—atherosclerosis	4.37e-05	0.000289	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—AGTR1—atherosclerosis	4.36e-05	0.000288	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—SPP1—atherosclerosis	4.36e-05	0.000288	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CCL2—atherosclerosis	4.35e-05	0.000287	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PLG—atherosclerosis	4.34e-05	0.000287	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—CXCL8—atherosclerosis	4.34e-05	0.000287	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—BGN—atherosclerosis	4.29e-05	0.000283	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—KNG1—atherosclerosis	4.29e-05	0.000283	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—IGF1—atherosclerosis	4.28e-05	0.000283	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—CCL2—atherosclerosis	4.28e-05	0.000282	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—AGTR1—atherosclerosis	4.26e-05	0.000282	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PLG—atherosclerosis	4.25e-05	0.000281	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—APOA5—atherosclerosis	4.25e-05	0.000281	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—CCL2—atherosclerosis	4.18e-05	0.000276	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PLG—atherosclerosis	4.16e-05	0.000274	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—SOCS3—atherosclerosis	4.11e-05	0.000272	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	4.09e-05	0.00027	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—SERPINE1—atherosclerosis	4.06e-05	0.000268	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PDGFB—atherosclerosis	4.04e-05	0.000266	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—SOCS3—atherosclerosis	4.02e-05	0.000266	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MMP3—atherosclerosis	3.97e-05	0.000262	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IGF2—atherosclerosis	3.96e-05	0.000261	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ALOX5—atherosclerosis	3.95e-05	0.000261	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—AGT—atherosclerosis	3.94e-05	0.00026	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—SOCS3—atherosclerosis	3.94e-05	0.00026	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MMP3—atherosclerosis	3.89e-05	0.000257	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—NOS3—atherosclerosis	3.88e-05	0.000256	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IGF2—atherosclerosis	3.87e-05	0.000255	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—APOE—atherosclerosis	3.86e-05	0.000255	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—LEP—atherosclerosis	3.86e-05	0.000255	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—APOB—atherosclerosis	3.84e-05	0.000254	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CAV1—atherosclerosis	3.82e-05	0.000252	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—APOA1—atherosclerosis	3.82e-05	0.000252	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—CXCL8—atherosclerosis	3.81e-05	0.000251	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MMP3—atherosclerosis	3.8e-05	0.000251	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IGF2—atherosclerosis	3.78e-05	0.00025	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—EDN1—atherosclerosis	3.78e-05	0.00025	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—APOB—atherosclerosis	3.76e-05	0.000248	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CCL5—atherosclerosis	3.75e-05	0.000248	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—CXCL8—atherosclerosis	3.73e-05	0.000246	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—EDN1—atherosclerosis	3.7e-05	0.000244	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—ESR1—atherosclerosis	3.69e-05	0.000243	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—APOB—atherosclerosis	3.67e-05	0.000243	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CCL5—atherosclerosis	3.67e-05	0.000242	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—LPL—atherosclerosis	3.67e-05	0.000242	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—CXCL8—atherosclerosis	3.64e-05	0.00024	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—F2—atherosclerosis	3.64e-05	0.00024	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—EDN1—atherosclerosis	3.62e-05	0.000239	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CCL5—atherosclerosis	3.59e-05	0.000237	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—LPL—atherosclerosis	3.59e-05	0.000237	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PRKCG—atherosclerosis	3.57e-05	0.000235	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—NAMPT—atherosclerosis	3.54e-05	0.000234	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—LIPC—atherosclerosis	3.52e-05	0.000232	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—LPL—atherosclerosis	3.51e-05	0.000232	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—APOC3—atherosclerosis	3.5e-05	0.000231	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PRKCG—atherosclerosis	3.49e-05	0.00023	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PIK3CG—atherosclerosis	3.48e-05	0.00023	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—LDLR—atherosclerosis	3.48e-05	0.00023	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—SPP1—atherosclerosis	3.47e-05	0.000229	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—CXCL8—atherosclerosis	3.46e-05	0.000228	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CXCL8—atherosclerosis	3.44e-05	0.000227	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PRKCG—atherosclerosis	3.41e-05	0.000225	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—SPP1—atherosclerosis	3.4e-05	0.000224	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CETP—atherosclerosis	3.4e-05	0.000224	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—CXCL8—atherosclerosis	3.38e-05	0.000223	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—MAPK3—atherosclerosis	3.34e-05	0.00022	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—AKT1—atherosclerosis	3.32e-05	0.000219	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—SPP1—atherosclerosis	3.32e-05	0.000219	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—CXCL8—atherosclerosis	3.31e-05	0.000218	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—INS—atherosclerosis	3.3e-05	0.000218	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—IL6—atherosclerosis	3.27e-05	0.000216	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—SCARB1—atherosclerosis	3.25e-05	0.000215	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CCL2—atherosclerosis	3.24e-05	0.000214	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PDGFB—atherosclerosis	3.21e-05	0.000212	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—IGF1—atherosclerosis	3.19e-05	0.000211	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PDGFB—atherosclerosis	3.14e-05	0.000208	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—AGT—atherosclerosis	3.14e-05	0.000207	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—MMP9—atherosclerosis	3.11e-05	0.000206	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—NFKB1—atherosclerosis	3.08e-05	0.000203	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PDGFB—atherosclerosis	3.07e-05	0.000203	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—LEP—atherosclerosis	3.07e-05	0.000203	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—APOE—atherosclerosis	3.07e-05	0.000203	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—HMGCR—atherosclerosis	3.07e-05	0.000203	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—AGT—atherosclerosis	3.07e-05	0.000203	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CAV1—atherosclerosis	3.05e-05	0.000201	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—APOA1—atherosclerosis	3.04e-05	0.000201	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—SERPINE1—atherosclerosis	3.03e-05	0.0002	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—MAPK8—atherosclerosis	3.03e-05	0.0002	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—AKT1—atherosclerosis	3.02e-05	0.000199	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—LEP—atherosclerosis	3.01e-05	0.000199	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—APOE—atherosclerosis	3.01e-05	0.000199	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—AGT—atherosclerosis	3e-05	0.000198	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CAV1—atherosclerosis	2.98e-05	0.000197	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—APOA1—atherosclerosis	2.97e-05	0.000196	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—APOE—atherosclerosis	2.94e-05	0.000194	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—LEP—atherosclerosis	2.94e-05	0.000194	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—ESR1—atherosclerosis	2.93e-05	0.000194	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CAV1—atherosclerosis	2.91e-05	0.000192	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—APOA1—atherosclerosis	2.91e-05	0.000192	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—F2—atherosclerosis	2.9e-05	0.000191	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—NOS3—atherosclerosis	2.89e-05	0.000191	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—ESR1—atherosclerosis	2.87e-05	0.00019	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—F2—atherosclerosis	2.84e-05	0.000187	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—ESR1—atherosclerosis	2.81e-05	0.000185	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—VEGFA—atherosclerosis	2.8e-05	0.000185	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PIK3CG—atherosclerosis	2.77e-05	0.000183	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—F2—atherosclerosis	2.77e-05	0.000183	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—STAT3—atherosclerosis	2.77e-05	0.000183	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ABCA1—atherosclerosis	2.74e-05	0.000181	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PIK3CG—atherosclerosis	2.71e-05	0.000179	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—MAPK3—atherosclerosis	2.66e-05	0.000175	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PIK3CG—atherosclerosis	2.65e-05	0.000175	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—MAPK3—atherosclerosis	2.64e-05	0.000175	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—INS—atherosclerosis	2.63e-05	0.000173	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—MAPK3—atherosclerosis	2.6e-05	0.000172	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CCL2—atherosclerosis	2.58e-05	0.000171	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—INS—atherosclerosis	2.57e-05	0.00017	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—TGFB1—atherosclerosis	2.57e-05	0.000169	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CXCL8—atherosclerosis	2.56e-05	0.000169	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—MAPK3—atherosclerosis	2.54e-05	0.000168	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IGF1—atherosclerosis	2.54e-05	0.000168	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CCL2—atherosclerosis	2.53e-05	0.000167	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—INS—atherosclerosis	2.51e-05	0.000166	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IGF1—atherosclerosis	2.48e-05	0.000164	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—AKT1—atherosclerosis	2.48e-05	0.000164	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CCL2—atherosclerosis	2.47e-05	0.000163	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—IL6—atherosclerosis	2.44e-05	0.000161	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IGF1—atherosclerosis	2.43e-05	0.00016	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—SERPINE1—atherosclerosis	2.41e-05	0.000159	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—SERPINE1—atherosclerosis	2.36e-05	0.000156	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—HMOX1—atherosclerosis	2.35e-05	0.000155	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MMP9—atherosclerosis	2.32e-05	0.000153	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—SERPINE1—atherosclerosis	2.31e-05	0.000152	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—NOS3—atherosclerosis	2.3e-05	0.000152	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—NFKB1—atherosclerosis	2.3e-05	0.000152	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MAPK8—atherosclerosis	2.26e-05	0.000149	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—NOS3—atherosclerosis	2.25e-05	0.000149	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—AKT1—atherosclerosis	2.25e-05	0.000149	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—APOB—atherosclerosis	2.25e-05	0.000149	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—NOS3—atherosclerosis	2.2e-05	0.000145	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GSTM1—atherosclerosis	2.19e-05	0.000145	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—LPL—atherosclerosis	2.15e-05	0.000142	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GPX1—atherosclerosis	2.1e-05	0.000138	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—VEGFA—atherosclerosis	2.08e-05	0.000138	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—STAT3—atherosclerosis	2.06e-05	0.000136	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CXCL8—atherosclerosis	2.04e-05	0.000135	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CD36—atherosclerosis	2.04e-05	0.000135	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CXCL8—atherosclerosis	2e-05	0.000132	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—AKT1—atherosclerosis	1.97e-05	0.00013	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MAPK3—atherosclerosis	1.97e-05	0.00013	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CXCL8—atherosclerosis	1.95e-05	0.000129	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—IL6—atherosclerosis	1.94e-05	0.000128	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—MTHFR—atherosclerosis	1.93e-05	0.000128	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—IL6—atherosclerosis	1.93e-05	0.000128	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—AKT1—atherosclerosis	1.93e-05	0.000127	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—TGFB1—atherosclerosis	1.91e-05	0.000126	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—IL6—atherosclerosis	1.9e-05	0.000125	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PPARA—atherosclerosis	1.9e-05	0.000125	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—AKT1—atherosclerosis	1.89e-05	0.000125	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—IL6—atherosclerosis	1.86e-05	0.000123	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MMP9—atherosclerosis	1.85e-05	0.000122	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—AGT—atherosclerosis	1.84e-05	0.000121	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—NFKB1—atherosclerosis	1.83e-05	0.000121	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MMP9—atherosclerosis	1.81e-05	0.000119	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—APOE—atherosclerosis	1.8e-05	0.000119	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MAPK8—atherosclerosis	1.8e-05	0.000119	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—AKT1—atherosclerosis	1.79e-05	0.000118	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—NFKB1—atherosclerosis	1.79e-05	0.000118	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CAV1—atherosclerosis	1.78e-05	0.000118	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—AKT1—atherosclerosis	1.78e-05	0.000118	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—APOA1—atherosclerosis	1.78e-05	0.000118	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MMP9—atherosclerosis	1.77e-05	0.000117	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MAPK8—atherosclerosis	1.76e-05	0.000116	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—AKT1—atherosclerosis	1.75e-05	0.000116	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—NFKB1—atherosclerosis	1.75e-05	0.000115	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MAPK8—atherosclerosis	1.72e-05	0.000113	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—AKT1—atherosclerosis	1.71e-05	0.000113	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—VEGFA—atherosclerosis	1.66e-05	0.00011	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—STAT3—atherosclerosis	1.64e-05	0.000108	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PIK3CG—atherosclerosis	1.63e-05	0.000107	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—VEGFA—atherosclerosis	1.62e-05	0.000107	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—STAT3—atherosclerosis	1.61e-05	0.000106	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—VEGFA—atherosclerosis	1.59e-05	0.000105	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—STAT3—atherosclerosis	1.57e-05	0.000104	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MAPK3—atherosclerosis	1.57e-05	0.000104	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PPARG—atherosclerosis	1.57e-05	0.000104	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—INS—atherosclerosis	1.54e-05	0.000102	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MAPK3—atherosclerosis	1.54e-05	0.000101	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—TGFB1—atherosclerosis	1.52e-05	0.000101	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MAPK3—atherosclerosis	1.5e-05	9.91e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TGFB1—atherosclerosis	1.49e-05	9.83e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TGFB1—atherosclerosis	1.46e-05	9.62e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—IL6—atherosclerosis	1.44e-05	9.51e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ALB—atherosclerosis	1.41e-05	9.31e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—NOS3—atherosclerosis	1.35e-05	8.91e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—AKT1—atherosclerosis	1.33e-05	8.78e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PTGS2—atherosclerosis	1.23e-05	8.15e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IL6—atherosclerosis	1.15e-05	7.58e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IL6—atherosclerosis	1.12e-05	7.41e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IL6—atherosclerosis	1.1e-05	7.25e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—AKT1—atherosclerosis	1.06e-05	6.99e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—AKT1—atherosclerosis	1.04e-05	6.84e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—AKT1—atherosclerosis	1.01e-05	6.68e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—AKT1—atherosclerosis	6.2e-06	4.09e-05	CbGpPWpGaD
